PTO/AlA/14 (08—12)
`Approved for use through 01/31!2014. OMB 06510032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`069804—0349
`
`Attorney Docket Number
`
`
`Application Data Sheet 37 CFR 1.76
`13/6272811
`Application Number
`Title of invention
`A METHOD FOR iMMOBiLiZiNG GLUCOSE OXiDASE ON A SELF—ASSEMBLED MONOLAYER
`
`
`l
`
`
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`F
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`E] 37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`inventor information:
`.
`"i
`
`inventor
`1
`
`
`Legal Name
`
`
`
`Middle Name
`Family Name
`
`
`i HATAOKA
`J
`
`Residence information (Select One) 0 US Residency @ Non US Residency 0 Active US Military Service
`City
`Osaka
`'Country of Residence
`i
`l“)
`
`
`
`
`Mailing Address of inventor:
`
`
`
`
`Address 1
`
`
`c/oRanascnicGorporatien. -—~-
`c/o Panasonic Healthcarc CO., Ltd.
`
`
`Address 2
`WQOazaKadoma— 2131—1, Minamigata, Toon-shi
`City
`Kadonieshkesaka—— Ehimc
`State/Province
`i
`
`Postal Code
`57-1a8591791«0395
`Country I
`JP
`
`A
`inventor information blocks may be
`inventors Must Be Listed - Additional
`Ail
`generated within this form by selecting the Add button.
`dd
`
`
`Correspondence Information:
`
`
`Enter either Customer Number or complete the Correspondence information section below.
`For further information see 37 CFR 1.33(a).
`
`
`[:] An Address is being provided for the correspondence information of this application.
`
`Customer Number
`
`@3989
`
`
`20277
`
`Email Address
`washington_ip_docket@mwe.com
`i
`
`
`EFS Web 2.2.3
`
`

`

`PTO/AlA/14 (08-12)
`Approved for use through 01/31/2014. OMB 0651—0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number:
`
`Application Data Sheet 37 CFR 1.76
`132‘627,8 1 i
`Application Number
`
`
`Attorney Docket Number
`069804-0349
`
`
`
`Title of Invention
`A METHOD FOR lMMOBlLlZiNG GLUCOSE OXIDASE ON A SELF-ASSEMBLED MONOLAYER
`
`
`Application information:
`
`Title of the Invention
`A METHOD FOR iMMOBiLiZiNG GLUCOSE OXiDASE ON A SELF—ASSEMBLED MONOLAYER
`
`
`
`Attorney Docket Number
`069804—0349
`Small Entity Status Claimed
`[:3
`
`
`Application Type
`Nonprovisionai
`
`
`Subject Matter
`Utility
`
`
`
`
`Sub Class (if any)
`Suggested Class (if any)
`
`Suggested Technology Center (if any)
`
`3
`Total Number of Drawing Sheets (if any)
`Suggested Figure for Publication (if any)
`
`
`
`
`
`Publication information:
`
`Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`i hereby request that the attached application not be published under
`Request Not to PUbiiSh.
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application, Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. if both sections are completed the customer
`Number will be used for thr Representative information during processing.
`
`
`Please Select One:
`
`© Customer Number
`
`O US Patent Practitioner 0 Limited Recognition (37 CFR 119)
`
`Customer Number
`
`~5398Ei 20277
`
`Domestic Benefit/National Stage information:
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`
`Prior Application Status
`Pending
`I
`Application Number
`‘ Prior Application Number]
`Continuity Type
`Filing Date (YYYY-MM-DD)
`
`Continuation of I 2011-0721 i PCT/JP2011IOO4127
`
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`
`
`
`
`
`
`Add
`
`Foreign Priority information:
`
`EFS Web 223
`
`

`

`PTO/AlAlM (08—1 2
`Approved for use through 01/31/2014. OMB 0651—0032
`US Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`069804—0349
`
`Attorney Docket Number
`b
`Application Data Sheet 37 CFR1.76 ' A [_
`f
`N
`13/627,81 i
`ppicaion um er
`
`A METHOD FOR IMMOBILIZlNG GLUCOSE OXlDASE ON A SELF-ASSEMBLED MONOLAYER
`Title of Invention
`
`
`
`
`
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR i.55(a).
`
`
`ti
`
`Application Number
`Country i
`Filing Date (YYYY-MM-DD)
`Priority Claimed
`2010—2341314
`2010—10—19
`
`@ Yes O No
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Add
`
`Authorization to Permit Access:
`
` Z] Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean intellectual Property Office (KlPO), the World intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 144(0) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WlPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`
`
`
`in accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: t) the instant patent application-as—filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S,C. 119(a)—{d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any US. application-as—filed from which benefit is
`sought in the instant patent application.
`
`in accordance with 37 CFR 114(0), access may be provided to information concerning the date of filing this Authorization,
`
`Applicant information:
`
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`EFS Web 223
`
`

`

`PTO/AlA/M (08—12)
`Approved for use through 01/31/2014. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1 76 l Attorney Docket Number
`069804-0349
`'
`I Application Number
`1 13/627,811
`
`Title of Invention A METHOD FOR lMMOBlLlZlNG GLUCOSE OXlDASE ON A SELF—ASSEMBLED MONOLAYER
`
`
`
`
`l
`'
`l
`
`
`
`
`
`AssigneeG) 0 Legal Representative under 35 U.S.C, 117
`
`
`
`0
`
`Person to whom the inventor is obligated to assign.
`
`0 Person who shows sufficient proprietary interest
`
`if applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`i...
`
`.
`Name of the Deceased or Legally incapaCItated inventor :!
`
`
`
`if the Assignee is an Organization check here.
`x
`
`
`
`
`
`organization Name
`
`-Panasonic€orporatiorr
`
`
`PANASONIC HEALTHCARE HOLDINGS co, LTD.
`
`
`Mailing Address Information:
`
`
`-1966;-Oaza—Kadema- 2—38—5 NishishimbashiLMinato-ku
`Address 1
`Address 2
`’1
`
`
`
`
`-Kadom=shtflsaka- Tokyo
`City
`StatelProvince
`
`
`Country i
`JP
`Postal Code
`«57—1-8501- 105-8433
`Fax Number
`r Phone Number
`|
`Email Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`
`Remove
`
`
`Signature:
`NOTE: This form must be signed in accordancb Witt; 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`z?"
`{3’
`
`certifications
`*
`
`Applicant 1
`if the applicant is the inventor {or the remaining joint inventor or inventors under 37 CFR 1145), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. if the applicant is an
`applicant under 37 CF R 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`
`1
`
`Signature
`
`lmichael e. fogarty/
`
`First Name
`..__
`
`Michael
`
` Date (YYYY—MM-DD)‘2015~O4-08
`
`I Registration Number | 36139
`Add
`Additional Signature may be generated éthln {his form by selecting the Add button.
`
`
`
`
`EFS Web 223
`
`

`

`PTO/AlA/M (08—1 2
`Approved for use through 01/31/2014, OMB 0651-0032
`US. Patent and Trademark Office; US DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number,
`
`
`
`
`| Attorney Docket Number
`069804—0349
`
`Application Data Sheet 37 CFR 1.76
`i Application Number
`13/627,811
`
`A METHOD FOR IMMOBILIZING GLUCOSE OXlDASE ON A SELF—ASSEMBLED MONOLAYER
`
`Title of invention
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U,S_Ct 122 and 37’ CFR 1.14, This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and
`Trademark Office, US, Department of Commerce, PO. Box 1450, Alexandria, VA 22313—1450. DO NOT SEND FEES OR
`
`COMPLETED FORMS TO THIS ADDRESS. SEND To: Commissioner for Patents, PO. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 22.3
`
`

`

`Privacy Act Statement
`
`
`
`The Privacy Act of 1974 (PL 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`if you do not
`fumish the requested information, the US Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent,
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of information Act (5 USC. 552)
`and the Privacy Act (5 U.S.C. 5523), Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract, Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 USO 5523(m),
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the international Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty,
`
`A record in this system of records may be disc osed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be d‘sclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under author‘ty of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals,
`
`
`
`A record from this system of records may be d‘sclosed, as a routine use, to the public after either publication of the application pursuan
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 USC. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by ether a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be d‘sclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.23
`
`